Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib

Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib

US Patent 12295925 · Granted May 13, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mirdametinib treatment2025
Mirdametinib treatment2025
Mirdametinib treatment2025
Dosage forms of mirdametinib2025
Dosage forms of mirdametinib2025
Mirdametinib treatment2025
Mirdametinib treatment2025
Mirdametinib treatment2025
Non-linear dosing of mirdametinib2025
Non-linear dosing of mirdametinib2025
Non-linear dosing of mirdametinib2025
Mirdametinib treatment2025